Invenomic Capital Management’s Tennant Co TNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Sell
182,387
-167,005
-48% -$13.9M 0.95% 38
2026
Q1
$23.2M Buy
349,392
+18,218
+6% +$1.32M 1.06% 34
2025
Q4
$24.4M Buy
331,174
+1,259
+0.4% +$96.2K 1.14% 24
2025
Q3
$26.7M Sell
329,915
-20,549
-6% -$1.68M 1.29% 21
2025
Q2
$27.2M Buy
350,464
+70,664
+25% +$5.22M 1.54% 19
2025
Q1
$22.3M Buy
279,800
+205,596
+277% +$17.4M 1.13% 23
2024
Q4
$6.05M Buy
+74,204
New +$6.53M 0.29% 104

Other funds holding TNC

Invenomic Capital Management's TNC Position: Q2 2026 in Review

Invenomic Capital Management reduced its Tennant Co (TNC) stake by 48% in Q2 2026, selling an estimated $13.9M and leaving 182,387 shares worth $16M. The position accounts for 0.95% of the portfolio, ranked #38.

Invenomic Capital Management first reported a position in TNC in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.2M in Q2 2025. 239 funds tracked by Wall St. Rank hold TNC as of Q2 2026.

  • Invenomic Capital Management held 182,387 shares of Tennant Co worth $16M as of Q2 2026.
  • Invenomic Capital Management sold 167,005 Tennant Co shares in Q2 2026, an estimated $13.9M.
  • Tennant Co made up 0.95% of Invenomic Capital Management's portfolio in Q2 2026, its #38 holding.
  • Invenomic Capital Management first reported a position in Tennant Co in Q4 2024 and has held it in 7 quarters since.
  • Invenomic Capital Management's Tennant Co position peaked at $27.2M in Q2 2025.
  • 239 funds tracked by Wall St. Rank held Tennant Co as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.